31/08/2026
Senior medical scientific liaison – northern italy
Tutta italia (IT)

Acadia Pharmaceuticals is dedicated to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities worldwide. The company’s commercial portfolio includes FDA‑approved treatments for Parkinson’s disease psychosis and Rett syndrome, and its pipeline spans mid‑to‑late‑stage programs in Alzheimer’s disease, Lewy body dementia, and other neurodegenerative conditions.